✦ LIBER ✦

Safety of high doses of a monoclonal antibody-purified factor IX concentrate

✍ Scribed by Dr. Indira Warrier; Carol K. Kasper; Gilbert C. White II; Amy D. Shapiro; Garrett E. Bergman

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 210 KB
Volume: 49
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.2830490117

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of purified factor I

Safety and efficacy of purified factor IX concentrate and antifibrinolytic agents for dental extractions in hemophilia B

✍ Djulbegovic, Benjamin; Marasa, Mary; Pesto, Al; Kushner, George M.; Hadley, Tere 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 2 views

This study evaluated the safety and efficacy of combined treatment with E-aminocaproic acid or tranexamic acid and monoclonal antibody purified factor IX (MAb factor IX) for prophylaxis against bleeding in eight hemophilia B patients undergolng nine dental extraction procedures. Ail patients achieve

Response of a concentrated monoclonal an

Response of a concentrated monoclonal antibody formulation to high shear

✍ Jared S. Bee; Jennifer L. Stevenson; Bhavya Mehta; Juraj Svitel; Joey Pollastrin 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

## Abstract There is concern that shear could cause protein unfolding or aggregation during commercial biopharmaceutical production. In this work we exposed two concentrated immunoglobulin‐G1 (IgG1) monoclonal antibody (mAb, at >100 mg/mL) formulations to shear rates between 20,000 and 250,000 s^−1

Effectiveness of high-dose intravenous i

Effectiveness of high-dose intravenous immunoglobulin in a case of acquired von willebrand syndrome with chronic melena not responsive to desmopressin and factor VIII concentrate

✍ Dr. Giancarlo Castaman; Alberto Tosetto; Francesco Rodeghiero 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 463 KB 👁 2 views